Background
==========

Data from the ongoing NHLBI-supported Framingham Heart Study (FHS) on cardiovascular disease (CVD) was made available to Genetic Analysis Workshop 13 (GAW13). Two behaviors of general medical and psychiatric interest collected from this community-based sample were included in the data, i.e., alcohol consumption and cigarette consumption. Increased cigarette consumption in the FHS sample is associated with the development of CVD \[[@B1],[@B2]\], but increased alcohol consumption in the FHS is not, except in those aged 60--69 \[[@B3],[@B4]\], although meta-analyses of cohort and case-control samples, including the FHS \[[@B3]\], identify a protective effect of moderate (1--2 drinks/day) alcohol consumption \[[@B5]\]. The consumption of tobacco and alcohol confer significant risk for a variety of medical disorders other than CVD, e.g., oral and pharyngeal cancer \[[@B6]\] and for a common psychiatric comorbidity \[[@B7]\].

The consumption of these two substances varies significantly based on both sex and age and there has been a long-term decline in the consumption of cigarettes in the US in the latter half of the 20^th^century, due to health concerns and restrictions placed on this behavior \[[@B8]\]. The consumption of both substances is significantly correlated in the American population and the prevalence of consumption of alcohol and tobacco is increased by a factor of two in consumers of either substance \[[@B9]\]. The genetic influence on alcohol and tobacco dependence is significantly correlated in men \[[@B10]\]. Measures of consumption in multiple exams of the FHS provide an opportunity to study the genetic correlation of alcohol and tobacco consumption traits and search for susceptibility loci for these traits in a community-based sample.

Results
=======

Descriptive analysis of MAXAPD and MAXCPD
-----------------------------------------

There were a total of 4692 individuals in the GAW13 FHS sample, 2849 with a maximum alcohol consumption (MAXAPD) measure and 2881 with a maximum cigarette consumption (MAXCPD) measure. Descriptive statistics of the MAXAPD and MAXCPD traits and a square root transformation of MAXAPD, SRMAXAPD, are reported in Table [1](#T1){ref-type="table"}. The maximum alcohol consumption traits are highly non-normal and the distribution remained highly non-normal whether or not individuals with APD = 0 (*N*= 346) were included. Individual outlier trait values \> +4 standard deviations were changed to missing for analysis (without outliers); the individuals whose values were converted were predominantly male for all three traits but were mostly (≥80%) from Cohort 1 for APD traits (*N*= 28 for MAXAPD, *N*= 7 for SRMAXAPD) and from Cohort 2 for MAXCPD (*N*= 10). Removal of outliers brings SRMAXAPD and MAXCPD traits much closer to normality (Table [2](#T2){ref-type="table"}). Because MAXAPD remains highly non-normal even after positive outlier removal (Table [2](#T2){ref-type="table"}), correlation and linkage analysis results with MAXAPD are not reported.

Correlations of alcohol and cigarette consumption traits
--------------------------------------------------------

Familial correlations of relative and parental pairs (sex-specific and non-sex-specific) without extreme positive outliers for MAXCPD and SRMAXAPD are reported in Table [3](#T3){ref-type="table"}. For MAXCPD, only the correlation between sisters is greater than that between parents, with or without outliers. There are no familial correlations greater than the spousal correlation for SRMAXAPD, with or without outliers.

Sib-pair linkage analyses
-------------------------

In the single-point analysis, SRMAXAPD shows nominal evidence for linkage at 17 markers on 10 chromosomes with a *p*-value \< 0.01 (Table [4](#T4){ref-type="table"}). Chromosomes 7 and 9 have 3 markers each significant at a *p*-value \< 0.01. In addition, for this analysis treating sex as a covariate significantly predicted sib-pair trait covariance at *p*\< 0.01, while the regression analysis of age at which the maximum amount of alcohol was consumed and cohort did not provide nominal evidence for linkage at the *p*\< 0.05 level. Multi-point linkage analysis with SRMAXAPD identified chromosome 9 as the chromosome with the most significant multi-point linkage result in the 10 chromosomes evaluated. Thirteen consecutive markers on chromosome 9 showed evidence of linkage at *p*\< 0.05, with five of them showing significance at *p*\< 0.01. The most significant *p*-value observed on chromosome 9 was 3.77 × 10^-4^at marker c9g8 (Figure [1](#F1){ref-type="fig"}).

The single-point analysis for the trait for cigarette consumption, MAXCPD, found nominal evidence for linkage at nine markers on 7 chromosomes at *p*\< 0.05 (Table [5](#T5){ref-type="table"}). The effects of the covariates cohort, sex, and age at MAXCPD on sib-pair trait covariance were inconsistent. There was only one chromosome with more than one marker exhibiting nominal evidence for linkage. Multi-point results for MAXCPD were unremarkable.

Discussion
==========

In the genome-wide search for linkage evidence to maximum alcohol consumption, we found a number (*N*= 17) of marker loci that were nominally linked (*p*\< 0.01) with the maximum alcohol consumption traits, SRMAXAPD. A broad region on chromosome 9 exhibited the most significant evidence for linkage, with the maximum linkage evidence at \~66 cM (Table [4](#T4){ref-type="table"} and Figure [1](#F1){ref-type="fig"}). For the cigarette consumption trait, MAXCPD, we observed fewer loci (*N*= 9) with evidence for nominally significant (*p*\< 0.05) linkage and no loci at *p*\< 0.021. The low number of loci exhibiting nominal evidence for linkage to MAXCPD suggests that the MAXCPD trait, as investigated in this linkage analysis, lacks power to detect the influence of genetic susceptibility factors on maximum cigarette consumption.

Empirical *p*-values for the significance of linkage analysis results were not substantially different from asymptotic *p*-values for either trait, suggesting that assumptions of the SIBPAL regression model apply to the phenotypic and genotypic data analyzed in this study. Only the regions of maximum linkage to SRMAXAPD on chromosome 9 and the single-point linkage analysis result to SRMAXAPD on chromosome 17 at 89 cM provided statistical evidence for linkage at *p*\< 0.0007, a level considered \"significant\" by Lander and Kruglyak \[[@B11]\]. Multiple testing corrections in investigations of alcohol and cigarette consumption phenotypes performed independently, as in this study, would need to consider the significant correlation between the two behaviors \[[@B9]\].

Linkage studies of alcohol- and cigarette-related traits have identified regions of the genome with more than nominal evidence for linkage \[[@B12]\]. Regions of the genome that have been identified as nominally linked to phenotypes related to alcohol consumption include chromosome 1 (\~170 cM) and chromosome 7 (\~80--100 cM) for alcohol dependence \[[@B13],[@B14]\], chromosome 1 (\~200--250 cM) and chromosome 15 (\~70 cM) with a factor composed of later age of onset of drinking and increased harm avoidance \[[@B15]\], chromosome 4 (\~120 cM) for alcohol consumption \[[@B16]\], chromosome 1 (\~100--150 cM) for alcoholism or depression \[[@B17]\], chromosome 1 (\~100--150 cM) and chromosome 21 (\~80 cM) for alcohol sensitivity \[[@B18]\], all in the COGA sample \[[@B13]\], and chromosome 4 (\~70 cM) and chromosome 11 (\~0 cM) in the NIDDK/NIAAA American Indian sample \[[@B19]\]. Regions identified in this analysis of maximum alcohol consumption in the Framingham sample that correspond to the regions identified in the literature include chromosomes 1 \[[@B15]\], 4 \[[@B18]\], 7 \[[@B16]\], and 15 \[[@B15]\]. Regions of the genome that have been identified as nominally linked to phenotypes related to cigarette consumption in other samples include chromosome 1 (\~0 cM), chromosome 2 (\~90 cM), chromosome 14 (\~95 cM) for ever-smoking in the COGA sample \[[@B20]\], and chromosome 2 (\~145 cM) and chromosome 10 (\~120 cM) in the Christchurch sample \[[@B21]\]. There were no regions of the genome in the Framingham sample with nominal evidence of linkage to cigarette consumption that overlapped regions identified in the COGA and Christchurch samples exhibiting linkage to cigarette related phenotypes. However, in the FHS sample, chromosome 15 contains markers that exhibit nominal evidence for linkage to SRMAXAPD (Table [4](#T4){ref-type="table"}) and MAXCPD (Table [5](#T5){ref-type="table"}) at 60 cM and 72 cM, close to a region of chromosome 15 in the COGA sample exhibiting suggestive linkage to a factor composed of later age of onset of drinking and increased harm avoidance \[[@B15]\].

Conclusions
===========

We observed several marker loci with nominal evidence for linkage to the square-root transformed maximum alcohol consumption traits, SRMAXAPD, in the Framingham Heart Study sample. Some of the regions of the genome have been previously linked to alcoholism or related traits in Caucasian samples based on different ascertainment criteria.

Methods
=======

Selection of consumption data
-----------------------------

The traits of interest were defined as the maximum reported number of grams of alcohol per day (MAXAPD), and the maximum reported number of cigarettes smoked per day (MAXCPD). Exams 1, 2, 4, and 7 from FHS Cohort 1 and exams 1, 2, 3, and 4 from FHS Cohort 2 were chosen to assess MAXAPD and MAXCPD to utilize multiple exams at the earliest age possible to obtain measurements. Covariates of interest included cohort, age of maximum consumption measure, and sex.

Analysis of phenotypic, pedigree, and genotypic data
----------------------------------------------------

GAW13 FHS data were imported into a Microsoft Access database and exported in appropriate files for descriptive statistical analysis in SPSS Advanced Statistics or Microsoft Excel and familial correlation and linkage analysis in S.A.G.E. \[[@B22]\]. Familial correlations and the asymptotic standard errors were estimated using FCOR from S.A.G.E. 4.2. We used GENIBD from S.A.G.E. 4.2 to generate identity-by-descent (IBD) sharing distributions of the GAW13 data. Before running the GENIBD analysis, we used MEGA2 \[[@B23]\] to convert the GAW13 data to the column-delimited S.A.G.E. format.

SIBPAL from S.A.G.E. 4.2 was used to model the sib-pair covariance of traits reported as a function of marker allele identity-by-descent (IBD) sharing. Our analyses used estimated IBD information from the GENIBD procedure described above to perform single-point linkage analysis in which the mean corrected cross product of the trait was regressed onto the IBD information one trait at a time. The single-point linkage analysis was carried out separately for traits MAXAPD, SRMAXAPD, and MAXCPD, treated as continuous variables. The covariates sex, age of trait report, and cohort were included in the regression models. SRMAXAPD single-point linkage analysis was only performed without outliers. Empirical *p*-values were obtained for single-point linkage analysis of MAXCPD and SRMAXAPD to evaluate possible deviation from asymptotic *p-*values. Multi-point linkage analysis was performed using IBD distributions at multiple markers for MAXCPD and SRMAXAPD on those chromosomes showing nominal evidence (*p*\< 0.05 and *p*\< 0.01, respectively) for linkage at two or more consecutive loci.
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###### 

Non-normality of MAXAPD, SRMAXAPD, and MAXCPD, with outliers.

  Trait      *N*    Min   Max      Mean    Median   SD      Kurtosis   SE     Skewness   SE
  ---------- ------ ----- -------- ------- -------- ------- ---------- ------ ---------- ------
  MAXAPD     2849   0     624.00   23.34   11.00    35.80   57.88      0.09   5.39       0.05
  SRMAXAPD   2849   0     24.98    3.86    3.32     2.91    2.82       0.09   1.14       0.05
  MAXCPD     2881   0     95.00    13.93   10.00    15.61   0.96       0.09   1.06       0.05

###### 

Non-normality of MAXAPD, SRMAXAPD, and MAXCPD, without outliers.

  Trait      *N*    Min   Max      Mean    Median   SD      Kurtosis   SE     Skewness   SE
  ---------- ------ ----- -------- ------- -------- ------- ---------- ------ ---------- ------
  MAXAPD     2821   0     166.00   21.15   11.00    26.25   5.64       0.09   2.14       0.05
  SRMAXAPD   2842   0     15.43    3.82    3.32     2.80    0.77       0.09   0.84       0.05
  MAXCPD     2871   0     70.00    13.69   10.00    15.08   -0.03      0.09   0.88       0.05

###### 

Significant familial correlations of SRMAXAPD and MAXCPD without outliers.

  Correlation        MAXCPD   ± SE    SRMAXAPD   ± SE
  ------------------ -------- ------- ---------- -------
  father:son         0.058    0.041   0.133      0.041
  mother:son         0.018    0.042   0.097      0.039
  father:daughter    0.153    0.041   0.105      0.041
  mother:daughter    0.141    0.041   0.163      0.039
  brother:brother    0.179    0.045   0.150      0.046
  sister:brother     0.130    0.034   0.164      0.032
  sister:sister      0.268    0.046   0.186      0.045
  parent:offspring   0.072    0.023   0.102      0.022
  sibling:sibling    0.171    0.026   0.131      0.025
  mother:father      0.199    0.044   0.310      0.042

###### 

Markers exhibiting evidence (*p*-value \< 0.01) for linkage to SRMAXAPD.^A^

  Loci     Marker     Pairs   Regression Estimate   SE     *p-*Value
  -------- ---------- ------- --------------------- ------ -----------
  c1g27    D1S549     1455    1.55                  0.54   0.0023
  c4g3     D4S2633    1373    1.54                  0.55   0.0025
  c4g7     D4S3248    1432    1.47                  0.57   0.0051
  c6g10    D6S1053    1478    1.37                  0.54   0.0054
  c6g14    D6S1021    1428    1.42                  0.57   0.0061
  c7g10    D7S2204    1448    1.43                  0.51   0.0027
  c7g16    D7S1804    1426    1.34                  0.52   0.0049
  c7g22    D7S559     1382    1.63                  0.52   0.0010
  c9g8     D9S301     1410    1.75                  0.53   0.0005
  c9g9     D9S1122    1458    1.50                  0.59   0.0056
  c9g13    D9S910     1499    1.57                  0.60   0.0044
  c12g2    Unknown    1340    1.30                  0.52   0.0061
  c12g11   D12S1052   1458    1.35                  0.56   0.0084
  c15g7    D15S1507   1406    1.44                  0.58   0.0064
  c16g13   D16S539    1465    1.44                  0.55   0.0046
  c17g12   D17S1290   1485    1.63                  0.50   0.0006
  c22g4    D22S689    1470    1.39                  0.55   0.0058

^A^Linkage analysis via regression of the mean corrected cross product of SRMAXAPD to allele IBD information with covariates sex, age at SRMAXAPD, and cohort.

###### 

Markers exhibiting evidence (*p*-value \< 0.05) for linkage to MAXCPD.^A^

  Loci     Marker    Pairs   Regression Estimate   SE      *p*-Value
  -------- --------- ------- --------------------- ------- -----------
  c5g14    D5S1726   306     79.40                 38.79   0.021
  c6g1     Unknown   1425    43.24                 23.82   0.035
  c6g20    242zg51   1444    40.36                 21.61   0.031
  c8g3     D8S1130   1420    45.96                 22.89   0.022
  c9g18    308vb11   313     94.17                 55.44   0.045
  c15g9    D15S818   1103    50.77                 28.19   0.036
  c16g4    049xd21   1476    37.49                 21.63   0.042
  c20g9    321xd11   300     84.67                 43.70   0.027
  c20g10   D20S480   1412    41.11                 23.86   0.043

^A^Linkage analysis via regression of the mean corrected cross product of MAXCPD to allele IBD information with covariates sex, age at MAXCPD, and cohort.
